Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2012

01-06-2012 | Article

Persistence of uropathogenic Escherichia coli strains in the host for long periods of time: relationship between phylogenetic groups and virulence factors

Authors: A. Narciso, F. Nunes, T. Amores, L. Lito, J. Melo-Cristino, A. Duarte

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2012

Login to get access

Abstract

Escherichia coli cause the majority of urinary tract infections (UTIs). Virulence plays an important role in the initial stages of interaction with the host, facilitating colonization of the urinary tract tissue. The purpose of this study was to assess whether there is a relationship between virulence and antibiotic resistance in the persistence of uropathogenic E. coli strains. This study included five patients with UTI between 2001 and 2009. The antibiotic resistance phenotype of 29 E. coli isolates was determined by the disk diffusion method. Clonal relationship was determined through M13 polymerase chain reaction (PCR) fingerprinting. Phylogeny, virulence factors, β-lactamases, and replicon typing were studied through PCR. Antibiogram profiles were found from different patients and corresponded to CTX-M-2, CTX-M-15, CTX-M-32, and TEM-52 enzymes. Plasmids belonged essentially to incompatibility group IncF. No clonal relationship was observed among isolates from different patients, except for patients 4 and 5. Phylogenetic group A was predominant. Our work showed that commensal group A possesses the same virulence factors as the pathogenic groups B1 and D. E. coli common pilus and type 1 fimbriae could play an important role in the persistence in the host and in symptomatic UTI, respectively, which, combined with extended-spectrum β-lactamases (ESBLs), are a cause of the dissemination of microorganisms in the hospital and the community.
Literature
1.
go back to reference Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53–70PubMedCrossRef Foxman B (2003) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 49(2):53–70PubMedCrossRef
2.
go back to reference Escobar-Páramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguénec C, Denamur E (2004) A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 21(6):1085–1094PubMedCrossRef Escobar-Páramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguénec C, Denamur E (2004) A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 21(6):1085–1094PubMedCrossRef
3.
go back to reference Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United states, 2000–2001. J Infect Dis 190:1739–1744PubMedCrossRef Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA (2004) Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United states, 2000–2001. J Infect Dis 190:1739–1744PubMedCrossRef
4.
go back to reference Johnson JR, Owens K, Gajewski A, Kuskowski MA (2005) Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 43(12):6064–6072PubMedCrossRef Johnson JR, Owens K, Gajewski A, Kuskowski MA (2005) Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 43(12):6064–6072PubMedCrossRef
5.
go back to reference Piatti G, Mannini A, Balistreri M, Schito AM (2008) Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 46(2):480–487PubMedCrossRef Piatti G, Mannini A, Balistreri M, Schito AM (2008) Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 46(2):480–487PubMedCrossRef
6.
go back to reference Bradford PA (2001) Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14(4):933–951PubMedCrossRef Bradford PA (2001) Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14(4):933–951PubMedCrossRef
7.
go back to reference Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163–167PubMedCrossRef Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, Raz R (2004) Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163–167PubMedCrossRef
8.
9.
go back to reference Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370–1374PubMedCrossRef Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370–1374PubMedCrossRef
10.
go back to reference Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13(43):pii=19044 Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13(43):pii=19044
11.
go back to reference Barroso H, Freitas-Vieira A, Duarte A (1999) Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 β-lactamase. Antimicrob Agents Chemother 43(2):434–435PubMed Barroso H, Freitas-Vieira A, Duarte A (1999) Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 β-lactamase. Antimicrob Agents Chemother 43(2):434–435PubMed
12.
go back to reference Conceição T, Brízio A, Duarte A, Lito LM, Cristino JM, Salgado MJ (2005) First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob Agents Chemother 49(1):477–478PubMedCrossRef Conceição T, Brízio A, Duarte A, Lito LM, Cristino JM, Salgado MJ (2005) First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob Agents Chemother 49(1):477–478PubMedCrossRef
13.
go back to reference Brízio A, Vasco S, Gonçalves AR, Lito LM, Cristino JM, Salgado MJ, Duarte A (2006) Survey of extended-spectrum β-lactamases in Escherichia coli isolates from a Portuguese hospital and characterisation of a novel class 1 integron (In60A) carrying the bla CTX-M-9 gene. Int J Antimicrob Agents 28:320–324PubMedCrossRef Brízio A, Vasco S, Gonçalves AR, Lito LM, Cristino JM, Salgado MJ, Duarte A (2006) Survey of extended-spectrum β-lactamases in Escherichia coli isolates from a Portuguese hospital and characterisation of a novel class 1 integron (In60A) carrying the bla CTX-M-9 gene. Int J Antimicrob Agents 28:320–324PubMedCrossRef
14.
go back to reference Mammeri H, Poirel L, Fortineau N, Nordmann P (2006) Naturally occurring extended-spectrum cephalosporinases in Escherichia coli. Antimicrob Agents Chemother 50:2573–2576PubMedCrossRef Mammeri H, Poirel L, Fortineau N, Nordmann P (2006) Naturally occurring extended-spectrum cephalosporinases in Escherichia coli. Antimicrob Agents Chemother 50:2573–2576PubMedCrossRef
15.
go back to reference Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228PubMedCrossRef Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228PubMedCrossRef
16.
go back to reference Grundmann HJ, Towner KJ, Dijkshoorn L, Gerner-Smidt P, Maher M, Seifert H, Vaneechoutte M (1997) Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 35:3071–3077PubMed Grundmann HJ, Towner KJ, Dijkshoorn L, Gerner-Smidt P, Maher M, Seifert H, Vaneechoutte M (1997) Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 35:3071–3077PubMed
17.
go back to reference Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558PubMedCrossRef Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555–4558PubMedCrossRef
18.
go back to reference Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, Nica M, Le Bouguénec C (2001) Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med 5(3):303–310PubMedCrossRef Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, Nica M, Le Bouguénec C (2001) Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med 5(3):303–310PubMedCrossRef
19.
go back to reference Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM (1996) Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob Agents Chemother 40(2):509–513PubMed Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM (1996) Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob Agents Chemother 40(2):509–513PubMed
20.
go back to reference Cartelle M, del Mar Tomas M, Molina F, Moure R, Villanueva R, Bou G (2004) High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 48(6):2308–2313PubMedCrossRef Cartelle M, del Mar Tomas M, Molina F, Moure R, Villanueva R, Bou G (2004) High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 48(6):2308–2313PubMedCrossRef
21.
go back to reference Karim A, Poirel L, Nagarajan S, Nordmann P (2001) Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 201:237–241PubMed Karim A, Poirel L, Nagarajan S, Nordmann P (2001) Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 201:237–241PubMed
22.
go back to reference Poyart C, Mugnier P, Quesne G, Berche P, Trieu-Cuot P (1998) A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother 42(1):108–113PubMed Poyart C, Mugnier P, Quesne G, Berche P, Trieu-Cuot P (1998) A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother 42(1):108–113PubMed
23.
go back to reference Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Vu Thien H, Gouriou S, Picard B, Denamur E (2005) Genetic background of Escherichia coli and extended-spectrum β-lactamase type. Emerg Infect Dis 11(1):54–61PubMedCrossRef Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Vu Thien H, Gouriou S, Picard B, Denamur E (2005) Genetic background of Escherichia coli and extended-spectrum β-lactamase type. Emerg Infect Dis 11(1):54–61PubMedCrossRef
24.
go back to reference Carattoli A, Miriagou V, Bertini A, Loli A, Colinon C, Villa L, Whichard JM, Rossolini GM (2006) Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg Infect Dis 12(7):1145–1148PubMedCrossRef Carattoli A, Miriagou V, Bertini A, Loli A, Colinon C, Villa L, Whichard JM, Rossolini GM (2006) Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg Infect Dis 12(7):1145–1148PubMedCrossRef
25.
go back to reference Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, Denamur E, Arlet G (2009) Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother 63:67–71PubMedCrossRef Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, Denamur E, Arlet G (2009) Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother 63:67–71PubMedCrossRef
26.
go back to reference Picard B, Sevali Garcia J, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546–553PubMed Picard B, Sevali Garcia J, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67:546–553PubMed
27.
go back to reference Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128PubMed Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4:80–128PubMed
28.
go back to reference Wang H, Min G, Glockshuber R, Sun TT, Kong XP (2009) Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction. J Mol Biol 392:352–361PubMedCrossRef Wang H, Min G, Glockshuber R, Sun TT, Kong XP (2009) Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction. J Mol Biol 392:352–361PubMedCrossRef
29.
go back to reference Ruiz J, Simon K, Horcajada JP, Velasco M, Barranco M, Roig G, Moreno-Martínez A, Martínez JA, Jiménez de Anta T, Mensa J, Vila J (2002) Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 40(12):4445–4449PubMedCrossRef Ruiz J, Simon K, Horcajada JP, Velasco M, Barranco M, Roig G, Moreno-Martínez A, Martínez JA, Jiménez de Anta T, Mensa J, Vila J (2002) Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 40(12):4445–4449PubMedCrossRef
30.
go back to reference Rendón MA, Saldaña Z, Erdem AL, Monteiro-Neto V, Vázquez A, Kaper JB, Puente JL, Girón JA (2007) Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci USA 104(25):10637–10642PubMedCrossRef Rendón MA, Saldaña Z, Erdem AL, Monteiro-Neto V, Vázquez A, Kaper JB, Puente JL, Girón JA (2007) Commensal and pathogenic Escherichia coli use a common pilus adherence factor for epithelial cell colonization. Proc Natl Acad Sci USA 104(25):10637–10642PubMedCrossRef
31.
go back to reference Kärkkäinen UM, Ikäheimo R, Katila ML, Sivonen A, Siitonen A (2000) Low virulence of Escherichia coli strains causing urinary tract infection in renal disease patients. Eur J Clin Microbiol Infect Dis 19:254–259PubMedCrossRef Kärkkäinen UM, Ikäheimo R, Katila ML, Sivonen A, Siitonen A (2000) Low virulence of Escherichia coli strains causing urinary tract infection in renal disease patients. Eur J Clin Microbiol Infect Dis 19:254–259PubMedCrossRef
32.
go back to reference Hekker TA, Groeneveld AB, Simoons-Smit AM, de Man P, Connell H, MacLaren DM (2000) Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia. Eur J Clin Microbiol Infect Dis 19:312–316PubMedCrossRef Hekker TA, Groeneveld AB, Simoons-Smit AM, de Man P, Connell H, MacLaren DM (2000) Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia. Eur J Clin Microbiol Infect Dis 19:312–316PubMedCrossRef
33.
go back to reference Saldaña Z, Erdem AL, Schüller S, Okeke IN, Lucas M, Sivananthan A, Phillips AD, Kaper JB, Puente JL, Girón JA (2009) The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli. J Bacteriol 191(11):3451–3461PubMedCrossRef Saldaña Z, Erdem AL, Schüller S, Okeke IN, Lucas M, Sivananthan A, Phillips AD, Kaper JB, Puente JL, Girón JA (2009) The Escherichia coli common pilus and the bundle-forming pilus act in concert during the formation of localized adherence by enteropathogenic E. coli. J Bacteriol 191(11):3451–3461PubMedCrossRef
34.
go back to reference Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE (1995) Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis 172:440–445PubMedCrossRef Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE (1995) Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis 172:440–445PubMedCrossRef
35.
go back to reference Harder J, Bartels J, Christophers E, Schroder JM (2001)Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276(23):5707–5713PubMedCrossRef Harder J, Bartels J, Christophers E, Schroder JM (2001)Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276(23):5707–5713PubMedCrossRef
Metadata
Title
Persistence of uropathogenic Escherichia coli strains in the host for long periods of time: relationship between phylogenetic groups and virulence factors
Authors
A. Narciso
F. Nunes
T. Amores
L. Lito
J. Melo-Cristino
A. Duarte
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1431-7

Other articles of this Issue 6/2012

European Journal of Clinical Microbiology & Infectious Diseases 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.